462 related articles for article (PubMed ID: 19416257)
41. Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses.
Braathen LR; Paredes BE; Saksela O; Fritsch C; Gardlo K; Morken T; Frølich KW; Warloe T; Solér AM; Ros AM
J Eur Acad Dermatol Venereol; 2009 May; 23(5):550-5. PubMed ID: 19415804
[TBL] [Abstract][Full Text] [Related]
42. Photodynamic therapy of multiple actinic keratoses: reduced pain through use of visible light plus water-filtered infrared A compared with light from light-emitting diodes.
von Felbert V; Hoffmann G; Hoff-Lesch S; Abuzahra F; Renn CN; Braathen LR; Merk HF
Br J Dermatol; 2010 Sep; 163(3):607-15. PubMed ID: 20426780
[TBL] [Abstract][Full Text] [Related]
43. A pilot split-face study comparing conventional methyl aminolevulinate-photodynamic therapy (PDT) with microneedling-assisted PDT on actinically damaged skin.
Torezan L; Chaves Y; Niwa A; Sanches JA; Festa-Neto C; Szeimies RM
Dermatol Surg; 2013 Aug; 39(8):1197-201. PubMed ID: 23638986
[TBL] [Abstract][Full Text] [Related]
44. Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study.
Pariser D; Loss R; Jarratt M; Abramovits W; Spencer J; Geronemus R; Bailin P; Bruce S
J Am Acad Dermatol; 2008 Oct; 59(4):569-76. PubMed ID: 18707799
[TBL] [Abstract][Full Text] [Related]
45. Photodynamic therapy is more effective than imiquimod for actinic keratosis in organ transplant recipients: a randomized intraindividual controlled trial.
Togsverd-Bo K; Halldin C; Sandberg C; Gonzalez H; Wennberg AM; Sørensen SS; Wulf HC; Haedersdal M
Br J Dermatol; 2018 Apr; 178(4):903-909. PubMed ID: 28796885
[TBL] [Abstract][Full Text] [Related]
46. Combined daylight and conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis of the face and scalp: a new and efficient approach.
Salido-Vallejo R; Jiménez-Nájar F; Garnacho-Sucedo G; Vélez A
Arch Dermatol Res; 2020 Nov; 312(9):675-680. PubMed ID: 31838569
[TBL] [Abstract][Full Text] [Related]
47. Split-face study comparing conventional MAL photodynamic therapy in multiple actinic keratosis with complete time vs. half-time red light LED conventional illumination.
Fernández-Guarino M; Fonda Pascual P; Lizuain Gomez P; Harto Castaño A; Jaén Olasolo P
J Eur Acad Dermatol Venereol; 2019 Aug; 33(8):1529-1534. PubMed ID: 30868672
[TBL] [Abstract][Full Text] [Related]
48. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid.
Kasche A; Luderschmidt S; Ring J; Hein R
J Drugs Dermatol; 2006 Apr; 5(4):353-6. PubMed ID: 16673803
[TBL] [Abstract][Full Text] [Related]
49. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
Reinhold U; Dirschka T; Ostendorf R; Aschoff R; Berking C; Philipp-Dormston WG; Hahn S; Lau K; Jäger A; Schmitz B; Lübbert H; Szeimies RM
Br J Dermatol; 2016 Oct; 175(4):696-705. PubMed ID: 26921093
[TBL] [Abstract][Full Text] [Related]
50. Fully home-based methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face or scalp: A real life open study.
García-Gil MF; Gracia-Cazaña T; Cerro-Muñoz P; Bernal-Masferrer L; Navarro-Bielsa A; Gilaberte Y
Dermatol Ther; 2022 Nov; 35(11):e15879. PubMed ID: 36184916
[TBL] [Abstract][Full Text] [Related]
51. Pain during topical photodynamic therapy - comparing methyl aminolevulinate (Metvix
Yazdanyar S; Zarchi K; Jemec GBE
Photodiagnosis Photodyn Ther; 2017 Dec; 20():6-9. PubMed ID: 28780136
[TBL] [Abstract][Full Text] [Related]
52. Comparing cold-air analgesia, systemically administered analgesia and scalp nerve blocks for pain management during photodynamic therapy for actinic keratosis of the scalp presenting as field cancerization: a randomized controlled trial.
Klein A; Karrer S; Horner C; Werner A; Heinlin J; Zeman F; Koller M; Landthaler M; Szeimies RM; Gruber M; Graf B; Hansen E; Kerscher C
Br J Dermatol; 2015 Jul; 173(1):192-200. PubMed ID: 25413485
[TBL] [Abstract][Full Text] [Related]
53. Use of 5-Aminolevulinic Acid and Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses.
Shive ML; Coakley BJ; Bierman DF; Serowka Lane KL; Wiegell SR; Haedersdal M; Zachary CB
Dermatol Surg; 2019 Apr; 45(4):529-535. PubMed ID: 30807390
[TBL] [Abstract][Full Text] [Related]
54. Methyl aminolevulinate daylight photodynamic therapy applied at home for non-hyperkeratotic actinic keratosis of the face or scalp: an open, interventional study conducted in Germany.
Karrer S; Aschoff RAG; Dominicus R; Krähn-Senftleben G; Gauglitz GG; Zarzour A; Kerrouche N; Chavda R; Szeimies RM
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):661-666. PubMed ID: 30633376
[TBL] [Abstract][Full Text] [Related]
55. Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities.
Kaufmann R; Spelman L; Weightman W; Reifenberger J; Szeimies RM; Verhaeghe E; Kerrouche N; Sorba V; Villemagne H; Rhodes LE
Br J Dermatol; 2008 May; 158(5):994-9. PubMed ID: 18341663
[TBL] [Abstract][Full Text] [Related]
56. Daylight photodynamic therapy versus cryosurgery for the treatment and prophylaxis of actinic keratoses of the face - protocol of a multicenter, prospective, randomized, controlled, two-armed study.
Kohl E; Koller M; Zeman F; Szeimies RM; Philipp-Dormston WG; Prager W; Gerber PA; Karrer S
BMC Dermatol; 2017 Oct; 17(1):12. PubMed ID: 29070025
[TBL] [Abstract][Full Text] [Related]
57. Pretreatment with 5-Fluorouracil Cream Enhances the Efficacy of Daylight-mediated Photodynamic Therapy for Actinic Keratosis.
Nissen CV; Heerfordt IM; Wiegell SR; Mikkelsen CS; Wulf HC
Acta Derm Venereol; 2017 May; 97(5):617-621. PubMed ID: 28093604
[TBL] [Abstract][Full Text] [Related]
58. Clinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapy.
Szeimies RM; Torezan L; Niwa A; Valente N; Unger P; Kohl E; Schreml S; Babilas P; Karrer S; Festa-Neto C
Br J Dermatol; 2012 Jul; 167(1):150-9. PubMed ID: 22329784
[TBL] [Abstract][Full Text] [Related]
59. Daylight PDT with MAL - current data and practical recommendations of an expert panel.
Philipp-Dormston WG; Karrer S; Petering H; Ulrich C; Dirschka T; Berking C; Lonsdorf AS; Gerber PA; Radakovic S; Hunger RE; Szeimies RM
J Dtsch Dermatol Ges; 2015 Dec; 13(12):1240-9. PubMed ID: 26612792
[TBL] [Abstract][Full Text] [Related]
60. Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.
Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Hahn S; Pabst G; Voss D; Foguet M; Schmitz B; Lübbert H; Szeimies RM; ;
Br J Dermatol; 2013 Apr; 168(4):825-36. PubMed ID: 23252768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
